Last10K.com

Cyclacel Pharmaceuticals, Inc. (CYCC) SEC Filing 8-K Material Event for the period ending Wednesday, April 29, 2020

Cyclacel Pharmaceuticals, Inc.

CIK: 1130166 Ticker: CYCC

View differences made from one to another to evaluate Cyclacel Pharmaceuticals, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cyclacel Pharmaceuticals, Inc..

Continue

Assess how Cyclacel Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cyclacel Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: CYCC
CIK: 1130166
Form Type: 8-K Corporate News
Accession Number: 0001104659-20-056224
Submitted to the SEC: Mon May 04 2020 4:31:41 PM EST
Accepted by the SEC: Mon May 04 2020
Period: Wednesday, April 29, 2020
Industry: Pharmaceutical Preparations
Events:
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cycc/0001104659-20-056224.htm